Seqirus
Established in 2015, Seqirus manufactures and performs research on influenza vaccines. This company conducts research using both egg-based and cell-based technologies. Seqirus is headquartered in Maidenhead, United Kingdom.
Last updated on
About Seqirus
Estimated Revenue
$1B-$10BEmployees
1K-5KCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
325414Location
City
MaidenheadState
BerkshireCountry
United KingdomTech Stack (78)
